Clinical Trial Update: A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for a treatment in patients with mild-to-moderate systemic lupus erythematosus, currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Cugene Inc. | Conditions: Systemic Lupus Erythematosus, SLE (Systemic Lupus) | Phase 1 | Status: ACTIVE_NOT_RECRUITING